Persivia vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $107M strategic (May 2025) from Aldrich Capital. 200+ hospitals, 12,000+ clinicians. Patented Soliton AI engine. Global expansion in 2026. Spans care management, population health, and RCM.
About
Persivia is a unified AI healthcare platform spanning care management, population health analytics, and revenue cycle operations — one of the few integrated platforms that addresses both the clinical and financial sides of health system performance simultaneously. The company raised $107 million in strategic financing from Aldrich Capital Partners in May 2025, and is actively expanding globally in 2026 with its CareSpace platform deployed at 200+ hospitals and used by 12,000+ clinicians.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.